Mechanisms in Bradykinin Stimulated Arachidonate Release and Synthesis of Prostaglandin and Platelet Activating Factor

OpenBU

Show simple item record

dc.contributor.author Ricupero, D. en_US
dc.contributor.author Taylor, L. en_US
dc.contributor.author Tlucko, A. en_US
dc.contributor.author Navarro, J. en_US
dc.contributor.author Polgar, P. en_US
dc.date.accessioned 2012-01-11T21:40:11Z
dc.date.available 2012-01-11T21:40:11Z
dc.date.copyright 1992 en_US
dc.date.issued 1982 en_US
dc.identifier.citation Ricupero, D., L. Taylor, A. Tlucko, J. Navarro, P. Polgar. "Mechanisms in bradykinin stimulated arachidonate release and synthesis of prostaglandin and platelet activating factor" Mediators of Inflammation 1(2): 133-140. (1982) en_US
dc.identifier.issn 1466-1861 en_US
dc.identifier.uri http://hdl.handle.net/2144/3221
dc.description.abstract Regulatory mechanisms in bradykinin (BK) activated release of arachidonate (ARA) and synthesis of prostaglandin (PG) and platelet activating factor (PAF) were studied in bovine pulmonary artery endothelial cells (BPAEC). A role for GTP binding protein (G-protein) in the binding of BK to the cells was determined. Guanosine 5-O- (thiotriphosphate), (GTPτS), lowered the binding affinity for BK and increased the Kd for the binding from 0.45 to 1.99 nM. The Bmax remained unaltered at 2.25 × 10-11 mole. Exposure of the cells to aluminium fluoride also reduced the affinity for BK. Bradykinin-induced release of ARA proved pertussis toxin (PTX) sensitive, with a maximum sensitivity at 10 ug/ml PTX. GTPτS at 100 μM increased the release of arachidonate. The effect of GTPτS and BK was additive at suboptimal doses of BK up to 0.5 nM but never exceeded the levels of maximal BK stimulation at 50 nM. PTX also inhibited the release of ARA induced by the calcium ionophore, A23187. Phorbol 12-myristate 13-acetate or more commonly known as tetradecanoyl phorbol acetate (TPA) itself had little effect on release by the intact cells. However, at 100 nM it augmented the BK activated release. This was downregulated by overnight exposure to TPA and correlated with down-regulation of protein kinase C (PKC) activity. The down-regulation only affected the augmentation of ARA release by TPA but not the original BK activated release. TPA displayed a similar, but more potent amplification of PAF synthesis in response to both BK or the calcium ionophore A23187. These results taken together point to the participation of G-protein in the binding of BK to BPAEC and its activation of ARA release. Possibly two types of G-protein are involved, one associated with the receptor, the other activated by Ca2+ and perhaps associated with phospholipase A2 (PLA2). Our results further suggest that a separate route of activation, probably also PLA2 related, takes place through a PKC catalysed phosphorylation. en_US
dc.language.iso en en_US
dc.publisher Hindawi Publishing Corporation en_US
dc.rights Copyright 1992 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. en_US
dc.rights.uri http://creativecommons.org/licenses/by/ en_US
dc.title Mechanisms in Bradykinin Stimulated Arachidonate Release and Synthesis of Prostaglandin and Platelet Activating Factor en_US
dc.type article en_US
dc.identifier.doi 10.1155/S096293519200022X en_US
dc.identifier.pubmedid 18475453 en_US
dc.identifier.pmcid 2365329 en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search OpenBU


Advanced Search

Browse

Deposit Materials